Hand therapy or not following collagenase treatment for Dupuytren’s disease? A randomized controlled trial
Journal of Hand Therapy · 2026-04
DOI: 10.1016/j.jht.2026.02.004 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Hand Therapy, 2026-04. Verfasst von Terese Aglen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Therapy, Orthopedic Clinic, Haukeland University Hospital, Bergen, Norway. Electronic address: terese.aglen@helse-bergen.n…. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Western Norway Regional Health Authority, Norwegian Association for Hand Therapy.
Abstract (Originalsprache)
BACKGROUND Collagenase treatment can improve finger extension and hand function in patients with Dupuytren's disease. The role of hand therapy in enhancing or prolonging these effects remains unclear. PURPOSE The primary aim was to examine whether hand therapy, compared to no hand therapy, improves self-perceived occupational performance after collagenase treatment for Dupuytren's disease. The second aim was to investigate the effect of hand therapy on finger extension, grip strength, pain and overall patient impression. A third aim was to investigate whether outcomes differed between patients with metacarpophalangeal joint involvement only and those with combined metacarpophalangeal joint and proximal interphalangeal joint involvement. STUDY DESIGN Longitudinal randomized controlled trial with two parallel groups and four subgroups, registered at ClinicalTrials.gov. METHODS Seventy-two patients with collagenase treated Dupuytren's disease were randomized to receive either hand therapy (Therapy group) or no hand therapy (Control group). Each group was stratified by joint involvement. The Canadian Occupational Performance Measure (COPM) was the primary outcome. Secondary outcomes were Unité Rhumatologique des Affections de la Main scale, finger joint goniometer, Jamar dynamometer, Visual Analog Scale for pain, and Patient Global Impression of Change and of Satisfaction. RESULTS At 1-year follow-up, no differences (mean difference (CI), p-value) were found between Therapy and Control groups in COPM scores: Metacarpophalangeal joint groups: COPM-P -0.2 (-1.9-1.4), p=0.519; COPM-S -0.6 (-2.3,1.2), p=0.450. Proximal interphalangeal joint groups: COPM-P -0.2 (-1.9,1.5), p=0.972; COPM-S -0.5 (-2.4,1.4), p=0.579. No significant differences were noted in secondary outcomes, except for pain and grip force CONCLUSIONS: Hand therapy did not improve COPM outcomes 1 year after collagenase treatment. Referral to hand therapy may be most beneficial for patients experiencing pain or requiring strong grip force. Whether more hand therapy improves residual proximal interphalangeal joint contractures remains unanswered.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Occupational Therapy, Orthopedic Clinic, Haukeland University Hospital, Bergen, Norway. Electronic address: terese.aglen@helse-bergen.no.
- Department of Occupational Therapy, Orthopedic Clinic, Haukeland University Hospital, Bergen, Norway.
- Department of Plastic and Reconstructive Surgery and Hand Surgery, Erasmus MC - University Medical Center, Rotterdam, The Netherlands; Department of Rehabilitation Medicine, Erasmus MC - University Medical Center, Rotte…
- Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway.
- Department of Occupational Therapy, Orthopedic Clinic, Haukeland University Hospital, Bergen, Norway; Western Norway University of Applied Sciences, Bergen, Norway.
Förderung
- Western Norway Regional Health Authority
- Norwegian Association for Hand Therapy
Zitieren
APA
Aglen, T., Matre, K. H., Selles, R. W., Aßmus, J., & Taule, T. (2026). Hand therapy or not following collagenase treatment for Dupuytren’s disease? A randomized controlled trial. Journal of Hand Therapy. https://doi.org/10.1016/j.jht.2026.02.004
Vancouver
Aglen T, Matre KH, Selles RW, Aßmus J, Taule T. Hand therapy or not following collagenase treatment for Dupuytren’s disease? A randomized controlled trial. Journal of Hand Therapy. 2026. doi:10.1016/j.jht.2026.02.004
BibTeX
@article{Aglen2026,
author = {Aglen, Terese and Matre, Karin Hoegh and Selles, Ruud W and Aßmus, Jörg and Taule, Tina},
title = {Hand therapy or not following collagenase treatment for Dupuytren’s disease? A randomized controlled trial},
journal = {Journal of Hand Therapy},
year = {2026},
doi = {10.1016/j.jht.2026.02.004}
}
EUVIMED